Protagonist Therapeutics Inc buy Barclays PLC
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€103.58
Performance (%)
-1.70%
Price
20.03.26
€86.50
Summary
This prediction is currently active. With a performance of -1.70%, the BUY prediction for Protagonist Therapeutics Inc by Barclays_PLC is down slightly. This prediction currently runs until 19.03.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | -1.70% |
| iShares Core DAX® | -2.117% |
| iShares Nasdaq 100 | -1.323% |
| iShares Nikkei 225® | -0.324% |
| iShares S&P 500 | -1.568% |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Barclays PLC from $113.00 to $119.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€77.00
26.02.26
26.02.26
€95.61
26.02.27
26.02.27
12.34%
20.03.26
20.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€76.27
07.11.26
07.11.26
25.36%
20.03.26
20.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
17.09.25
17.09.25
€60.73
17.09.26
17.09.26
63.21%
20.03.26
20.03.26